INBRIJA Trademark

Trademark Overview

On Friday, May 26, 2017, a trademark application was filed for INBRIJA with the United States Patent and Trademark Office. The USPTO has given the INBRIJA trademark a serial number of 87980717. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Tuesday, December 23, 2025. This trademark is owned by ACORDA THERAPEUTICS, INC.. The INBRIJA trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

medical devices, namely, drug delivery system that facilitates the delivery of pharmaceutical and biological preparations used in the treatment of diseases, disorders or conditions of the nervous system

Pharmaceutical products, namely, pharmaceutical and biological preparations used in the treatment of diseases, disorders or conditions of the nervous system
inbrija

General Information

Serial Number87980717
Word MarkINBRIJA
Filing DateFriday, May 26, 2017
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, December 23, 2025
Registration Number5875276
Registration DateTuesday, October 1, 2019
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 24, 2017

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Translation of Words in MarkThe wording "INBRIJA" has no meaning in a foreign language
Description of MarkThe mark consists of the stylized wording "INBRIJA" next to a miscellaneous polygonal shape that resembles a curving triangle.
Goods and Servicesmedical devices, namely, drug delivery system that facilitates the delivery of pharmaceutical and biological preparations used in the treatment of diseases, disorders or conditions of the nervous system
Goods and ServicesPharmaceutical products, namely, pharmaceutical and biological preparations used in the treatment of diseases, disorders or conditions of the nervous system

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 2, 2017
Primary Code005
First Use Anywhere DateMonday, February 25, 2019
First Use In Commerce DateMonday, February 25, 2019
International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, June 2, 2017
Primary Code010
First Use Anywhere DateMonday, February 25, 2019
First Use In Commerce DateMonday, February 25, 2019

Trademark Owner History

Party NameMERZ PHARMACEUTICALS, LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressRALEIGH, NC 27615
Party NameACORDA THERAPEUTICS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressArdsley, NY 10502
Party NameACORDA THERAPEUTICS, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressArdsley, NY 10502
Party NameACORDA THERAPEUTICS, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressArdsley, NY 10502

Trademark Events

Event DateEvent Description
Tuesday, May 30, 2017NEW APPLICATION ENTERED
Friday, June 2, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, June 3, 2017NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, July 28, 2017ASSIGNED TO EXAMINER
Monday, August 14, 2017EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Monday, August 14, 2017COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Monday, August 14, 2017EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Monday, August 14, 2017NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Monday, August 28, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, September 10, 2017ASSIGNED TO LIE
Tuesday, September 12, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 12, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 13, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 4, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 24, 2017PUBLISHED FOR OPPOSITION
Tuesday, October 24, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 19, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, June 4, 2018SOU TEAS EXTENSION RECEIVED
Monday, June 4, 2018SOU EXTENSION 1 FILED
Monday, June 4, 2018SOU EXTENSION 1 GRANTED
Wednesday, June 6, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 4, 2018SOU TEAS EXTENSION RECEIVED
Tuesday, December 4, 2018SOU EXTENSION 2 FILED
Tuesday, December 4, 2018SOU EXTENSION 2 GRANTED
Thursday, December 6, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 4, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 4, 2019TEAS STATEMENT OF USE RECEIVED
Thursday, April 4, 2019TEAS REQUEST TO DIVIDE RECEIVED
Friday, April 26, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, April 4, 2019DIVISIONAL REQUEST RECEIVED
Tuesday, April 30, 2019DIVISIONAL PROCESSING COMPLETE
Thursday, April 4, 2019USE AMENDMENT FILED
Tuesday, April 30, 2019STATEMENT OF USE PROCESSING COMPLETE
Wednesday, May 1, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, May 17, 2019ASSIGNED TO EXAMINER
Wednesday, July 24, 2019SU - NON-FINAL ACTION - WRITTEN
Wednesday, July 24, 2019NON-FINAL ACTION E-MAILED
Wednesday, July 24, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, August 8, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, August 19, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 19, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 26, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, August 27, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, October 1, 2019REGISTERED-PRINCIPAL REGISTER
Thursday, December 2, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, December 2, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, December 2, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, December 2, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, December 2, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, October 1, 2024COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, January 15, 2025AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, September 11, 2025TEAS SECTION 8 & 15 RECEIVED
Monday, December 15, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, December 23, 2025REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, December 23, 2025NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Related Keywords

inbrija pharmaceutical system treatment used diseases nervous conditions disorders preparations biological